Benzinga's Top Upgrades, Downgrades For January 24, 2019

Top Upgrades

• BMO Capital upgraded Restaurant Brands International Inc QSR from Market Perform to Outperform. Restaurant Brands rose 0.8 percent to $63.11 in pre-market trading.
• William Blair upgraded Incyte Corporation INCY from Market Perform to Outperform. Incyte shares fell 2.75 percent to close at $75.20 on Wednesday.
• Berenberg upgraded Procter & Gamble Co PG from Sell to Hold. Procter & Gamble shares fell 0.2 percent to $94.70 in pre-market trading.
• Morgan Stanley upgraded Kimberly Clark Corp KMB from Underweight to Equal-Weight. Kimberly-Clark shares fell 2.72 percent to close at $112.15 on Wednesday.
• Cowen & Co. upgraded Fiserv Inc FISV from Market Perform to Outperform. Fiserv shares rose 3.07 percent to close at $80.59 on Wednesday.
• DA Davidson upgraded Duluth Holdings Inc DLTH from Neutral to Buy. Duluth shares rose 2.1 percent to close at $20.39 on Wednesday.
• Leerink Swann upgraded Ascendis Pharma A/S ASND from Market Perform to Outperform. Ascendis Pharma shares rose 0.5 percent to $73.37 in pre-market trading.
• JP Morgan upgraded Ironwood Pharmaceuticals, Inc. IRWD from Underweight to Neutral. Ironwood Pharmaceuticals shares fell 2.36 percent to close at $12.42 on Wednesday.
• Wedbush upgraded Palo Alto Networks Inc PANW from Neutral to Outperform. Palo Alto shares gained 2.3 percent to $210.50 in pre-market trading.
• Analysts at Oppenheimer upgraded Synchrony Financial SYF from Perform to Outperform. Synchrony Finl shares rose 1.6 percent to $29.87 in pre-market trading.

Top Downgrades

• Berenberg downgraded Mondelez International Inc MDLZ from Buy to Hold. Mondelez shares fell 1.2 percent to $43.00 in pre-market trading.
• Jefferies downgraded Weibo Corp WB from Buy to Hold. Weibo shares fell 1.3 percent to $51.51 in pre-market trading.
• Raymond James downgraded Northern Trust Corporation NTRS from Strong Buy to Market Perform. Northern Trust shares fell 0.66 percent to close at $89.93 on Wednesday.
• William Blair downgraded Aratana Therapeutics Inc PETX from Outperform to Market Perform. Aratana Therapeutics shares fell 2.8 percent to $4.14 in pre-market trading.
• Cowen & Co. downgraded Sothebys BID from Outperform to Market Perform. Sothebys shares fell 0.89 percent to close at $41.05 on Wednesday.
• Wells Fargo downgraded Canada Goose Holdings Inc GOOS from Outperform to Market Perform. Canada Goose shares fell 3.3 percent to $48.00 in pre-market trading.
• JMP Securities downgraded MINDBODY Inc MB from Outperform to Market Perform. MINDBODY shares fell 0.49 percent to close at $36.42 on Wednesday.
• Guggenheim downgraded Centurylink Inc CTL from Neutral to Sell. CenturyLink shares fell 3.4 percent to $14.70 in pre-market trading.
• Needham downgraded Microchip Technology Inc. MCHP from Strong Buy to Buy. Microchip Technology shares rose 2.1 percent to $75.93 in pre-market trading.
• Piper Jaffray downgraded Post Holdings Inc POST from Overweight to Neutral. Post Holdings shares dropped 1.5 percent to $98.00 in pre-market trading.

Top Initiations

• Analysts at Barclays initiated coverage on CVR Energy, Inc. CVI with an Underweight rating. The price target for CVR Energy is set to $47. CVR Energy closed at $38.31 on Wednesday.
• William Blair initiated coverage on AeroVironment, Inc. AVAV with an Outperform rating. AeroVironment shares closed at $73.60 on Wednesday.
• BTIG Research initiated coverage on Credit Acceptance Corp. CACC with a Sell rating. The price target for Credit Acceptance is set to $340. Credit Acceptance shares closed at $420.95 on Wednesday.
• Oppenheimer initiated coverage on Zendesk Inc ZEN with a Perform rating. Zendesk closed at $64.40 on Wednesday.
• Compass Point initiated coverage on First American Financial Corp FAF with a Buy rating. The price target for First American Financial is set to $58. First American Financial shares closed at $48.20 on Wednesday.
• Gabelli & Co. initiated coverage on Apergy APY with a Buy rating. Apergy shares closed at $33.18 on Wednesday.
• Cantor Fitzgerald initiated coverage on Ascendis Pharma A/S ASND with an Overweight rating. The price target for Ascendis Pharma is set to $102. Ascendis Pharma shares closed at $73.02 on Wednesday.
• Maxim Group initiates coverage on Bellerophon Therapeutics Inc BLPH with a Buy rating. The price target for Bellerophon Therapeutics is set to $3. Bellerophon Therapeutics shares closed at $0.67 on Wednesday.
• Compass Point initiated coverage on Re/Max Holdings Inc RMAX with a Neutral rating. RE/MAX Holdings shares closed at $37.39 on Wednesday.
• Analysts at Compass Point initiated coverage on Redfin Corp RDFN with a Buy rating. The price target for Redfin is set to $20.50. Redfin closed at $15.86 on Wednesday.